Article 1221

Title of the article

The manifestation’s feature of atypical hemolytic uremic syndrome using eculizumab (clinical case) 

Authors

Natal'ya N. Guranova, Candidate of medical sciences, associate professor, associate professor of the sub-department of faculty therapy with courses of physiotherapy and physical therapy, Ogarev Mordovia State University, Medical Institute (68 Bolshevistskaya street, Saransk, Russia), E-mail: nguranova@mail.ru
Anna A. Usanova, Doctor of medical sciences, professor, head of the sub-department of faculty therapy with courses of physiotherapy and physical therapy, Ogarev Mordovia State University, Medical Institute (68 Bolshevistskaya street, Saransk, Russia), E-mail: anna61-u@mail.ru
Irina Kh. Fazlova, Candidate of medical sciences, associate professor of the sub-department of faculty therapy with courses of physiotherapy and physical therapy, Ogarev Mordovia State University, Medical Institute (68 Bolshevistskaya street, Saransk, Russia), E-mail: fazlova@inbox.ru 
Ol'ga G. Radaykina, Candidate of medical sciences, associate professor of the sub-department of faculty therapy with courses of physiotherapy and physical therapy, Ogarev Mordovia State University, Medical Institute (68 Bolshevistskaya street, Saransk, Russia), E-mail: olgarus5@yandex.ru
Larisa S. Balyasnikova, Student, Ogarev Mordovia State University, Medical Institute (68 Bolshevistskaya street, Saransk, Russia), E-mail: larabalyasnikova@mail.ru

Index UDK

616.61-008.64 

DOI

10.21685/2072-3032-2021-2-1 

Abstract

Background. There is a clinical case of an atypical hemolytic-uremic syndrome (aHUS), beginning with symptoms of heavy damage of the gastrointestinal tract with prolonged repeated diarrhea and abdominal pain. They were imitating a pseudomembranous colitis, which was made possible to exclude due to the negative Clostridium Difficile test results and the lack of effect from treatment with vancomycin. The uniqueness of this case is in the rare occurrence of this pathology among the adult population . Timely diagnosis of aHUS, pathogenetic treatment help to reduce mortality.
Materials and methods. Analysis of the medical history and observation of the patient, who hospitalized in the nephrology department of the Republican Hospital of Saransk.
Results. Fulminant development of the disease with damage of the gastrointestinal tract, kidneys, lungs, microangiopathic hemolysis, thrombocytopenia, increased blood lactate dehydrogenase and decreased activity of ADAMTS 13 metalloproteinase have enabled to diagnose aHUS. Using pathogenetic complement-blocking therapy with Eculizumab achieved regression of clinical signs of the disease, normalization of laboratory parameters.
Conclusions. The course of aHUS is characterized by an unfavorable prognosis, the risk of sudden complications. The diagnosis of this disease based on clinical and laboratory signs of thrombotic microangiopathy, such as microangiopathic Coombs-negative hemolytic anemia, thrombocytopenia, multiple organ damage: acute damage to the kidneys, lungs (pneumonitis, atelectasis), intestines (erosive and ulcerative colitis), pancreas (subacute pancreatitis, transient hyperglycemia). Timely diagnosis allowed to achieve positive dynamics against the background of treatment with Eculizumab, which restores the regulation of the activity of the complement system in the blood. Therefore, patients with this diagnosis require special attention with lifelong monitoring and treatment, due to the high risk of sudden complications. 

Key words

atypical hemolytic-uremic syndrome, thrombotic microangiopathy, thrombotic thrombocytopenic purpura, thrombocytopenia, complement-blocking therapy 

Download PDF
References

1. Koloskov A.V., Mangushlo A.A. Metalloproteaza ADAMTS. Gematologiya i transfuziologiya = Hematology and transfusiology. 2019;64(4):471–482.
2. Scully M., Cataland S., Coppo P., de la Rubia J., Friedman K. D., Kremer Hovinga J., Lammle B., Matsumoto M., Pavenski K., Sadler E., Sarode R., Wu H. International Working Group for Thrombotic Thrombocytopenic Purpura. Consensus on the standardization of terminology in thrombotic thrombocytopenic purpura and related thrombotic microangiopathies. J Thromb Haemost. 2017;15(2):312–320.
3. Clark W.F., Patriquin S., Licht S., Huang S.H., Rock G.A. Simple diagnosis and treatment algorithm for adult thrombotic microangiopathy. Transfus Apher Sci. 2016, Dec 31. pii: S1473-0502(16)30204-X.
4. Appel G.B. Thrombotic microangiopathies: Similar presentations, different therapies. Cleve Clin J Med. 2017;101(2):395–415.
5. Shatzel J.J., Taylor J.A. Syndromes of Thrombotic Microangiopathy. Med Clin North Am. 2017;101(2):395–415.
6. Kobbe R., Schild R., Christner M., Oh J., Loos S., Kemper M.J. Case report – atypical hemolytic uremic syndrome triggered by influenza B. BMC Nephrol. 2017;18(1):1–4.
7. Kozlovskaya N.L., Prokopenko E.I., Emirova Kh.M., Serikova S.Yu. Clinical practice guidelines for the diagnosis and treatment of atypical hemolytic uremic syndrome. Nefrologiya i dializ = Nephrology and dialysis. 2015;17(3):242–264. (In Russ.)
8. Dem'yanova K.A., Bobrova L.A., Kozlov L.V., Andina S.S., Yurova V.A., Kuchieva A.M., Roshchupkina S.V., Shilov E.M. Comparative analysis of changes in the complement system in catastrophic antiphospholipid syndrome and atypical hemolytic uremic syndrome. Vestnik Rossiyskoy akademii meditsinskikh nauk = Bulletin of the Russian Academy of Medical Sciences. 2017;72(1):42–52. (In Russ.)
9. Fomina N.V., Chesnokova L.D., Konderova O.A., Smakotina S.A., Utkina E.V., Isaev V.Yu. Difficulties in diagnosing atypical hemolytic uremic syndrome. Sibirskiy nauchnyy meditsinskiy zhurnal = Siberian scientific medical journal. 2019;39(6):92–97. (In Russ.)
10. Rafiq A., Tariq H., Abbas N., Shenoy R. Atypical hemolitic-uremic syndrome: a case report and literature review. Am J Case Rep. 2015;16:109–114.
11. Shakhidzhanov S.S., Filippova A.E., Butylin A.A., Ataullakhanov F.I. Modern understanding of the complement system. Voprosy gematologii/onkologii i immunopatologii v pediatrii = Issues of hematology/oncology and immunopathology in pediatrics. 2019;18(3):130‒144. (In Russ.)
12. Chernova E.V. Von Willebrand factor. Vestnik Severo-Zapadnogo gosudarstvennogo meditsinskogo universiteta im. I. I. Mechnikova = Bulletin of the North-Western State Medical University named after I. I. Mechnikov. 2018;10(4):73–80. (In Russ.)

 

Дата создания: 24.08.2021 14:53
Дата обновления: 27.08.2021 12:37